These data suggest that abnormal SC α-synuclein accumulation may be an additional pathogenic biomarker for Parkinson’s disease and a new target for autonomic dysfunction in Parkinson’s disease by blocking the SC phosphorylated α-synuclein/TLR2 signaling pathway. Here, TLR2 is linked to Parkinson disease.